Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Jan;13(4):e09764.
doi: 10.1002/advs.202509764. Epub 2025 Nov 29.

A Robust Serum Proteomic Signature of the E2 Allele of Apolipoprotein E

Affiliations

A Robust Serum Proteomic Signature of the E2 Allele of Apolipoprotein E

Paola Sebastiani et al. Adv Sci (Weinh). 2026 Jan.

Abstract

A signature of 16 serum proteins that were previously profiled using the aptamer-based Somascan technology highlighted the roles of the e2 allele of APOE in lipid regulation via apolipoprotein B (APOB) and apolipoprotein E (APOE) and in inflammation. Here, the serum protein signature of APOE is validated and expanded using a combination of mass-spectrometry, ELISA, Luminex, blood transcriptomics, and antibody-based Olink serum proteomics. Some of the findings were replicated in the UK Biobank using antibody-based Olink serum proteomics. This analysis replicated the association between APOB and the e2 allele of APOE, detected a new, robust pattern of association between APOE genotypes and the serum level of APOE, and discovered new associations between APOE genotypes and the complex of apolipoproteins APOC1, APOC2, APOC3, APOC4, APOE, APOF, and APOL1. In addition, 13 new proteins correlated with APOE genotypes. This extended signature includes granule proteins CAMP, CTSG, DEFA3, and MPO secreted from neutrophils and points to olfactomedin 4 (OLFM4) as a new target for the prevention of Alzheimer's disease.

Keywords: APOE; aptameter‐based proteomics; gene expression; genetic variants; mass‐spectrometry; omics‐signatures.

PubMed Disclaimer

References

    1. M. E. Belloy, S. J. Andrews, Y. Le Guen, M. Cuccaro, L. A. Farrer, V. Napolioni, M. D. Greicius, JAMA Neurol. 2023, 80, 1284.
    1. R. J. Jackson, B. T. Hyman, A. Serrano‐Pozo, Nat. Rev. Neurol. 2024, 20, 457.
    1. P. Sebastiani, A. Gurinovich, M. Nygaard, T. Sasaki, B. Sweigart, H. Bae, S. L. Andersen, F. Villa, G. Atzmon, K. Christensen, Y. Arai, N. Barzilai, A. Puca, L. Christiansen, N. Hirose, T. T. Perls, J. Gerontol. A Biol. Sci. Med. Sci. 2019, 74, 44.
    1. B. Sweigart, S. L. Andersen, A. Gurinovich, S. Cosentino, N. Schupf, T. T. Perls, P. Sebastiani, J. Alzheimers Dis. 2021, 83, 853.
    1. R. Toribio‐Fernández, C. Tristão‐Pereira, S. Callejas, B. Oliva, I. Fernandez‐Nueda, I. Garcia‐Lunar, C. Perez‐Herreras, P. Martin, F. Blanco‐Kelly, C. Ayuso, E. Lara‐Pezzi, A. Fernandez‐Ortiz, A. Garcia‐Alvarez, A. Dopazo, F. Sanchez‐Cabo, B. Ibanez, M. Cortes‐Canteli, V. Fuster, Circ. Res. 2024, 134, 411.

LinkOut - more resources